- DARA Biosciences (DARA -12%) Q4 results: Revenues: $0.7M (+999%); Operating Expenses: $2.4M (-7.7%); Net Loss: ($1.6M) (+33.3%).
- FY2014 results: Revenues: $1.9M (+375.0%); Operating Expenses: $11.3M (+3.7%); Net Loss: ($9M) (+10.0%); Quick Assets: $12.1M (+255.9%).
- No guidance given.
DARA Biosciences Q4 and FY14 results
Recommended For You
More Trending News
About BDRX Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
BDRX | - | - |
Biodexa Pharmaceuticals Plc |